CUBEBIO

[Not Yet Scheduled]
CUBEBIO is an in-vitro diagnostic company and has developed a self-diagnostic device capable of early cancer detection by using urine as a specimen.

CUBEBIO is a Patron partner of Union for International Cancer Control (UICC). At the same time, CUBEBIO and UICC have jointly developed a global program, called “Cancer Early Detection and Self-Diagnosis,” to emphasize the significance of early detection and diagnosis.

Patron partnership is the highest partnership level within UICC. Its Patron partners include globally famous pharmaceutical companies, like Pfizer and Roche. UICC has more than 1,100 members and 55 partners across 171 countries, and only 9 of them are Patron partners. After a very particular selection process, CUBEBIO has become the world’s first small- and medium-sized enterprise to join UICC as its Patron partner and implement the exclusive global program.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Not Provided
Company HQ Country:
Korea - South Korea
Year Founded:
2011
Main Therapeutic Focus:
Lead Product in Development:
A cancer self-diagnostic device
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
CEO
CUBEBIO